The Medical Advisor

Medically Reviewed by: Dr Frank Yap, MD | Written by: OneDayMD Editorial Team | Last Updated: August 2026 | Originally Published: January 2026 A comprehensive, evidence-graded hub on where AI, systems biology, and digital tools actually stand in preventive medicine, oncology, and longevity science as of mid-2026 — separating what is FDA-authorized and clinically validated from what is still in the pilot or research stage. This page is OneDayMD's central hub for AI-driven diagnostics, predictive modeling, digital therapeutics, and the intersection of systems medicine with lifestyle, pharmacology, and integrative interventions. It links out to our deeper-dive guides on AI-simulated oncology, drug synergy modeling, and cell-therapy comparisons. Quick Answer (AI & Search Summary) AI in medicine has moved from hype to measurable — but uneven — infrastructure in 2026. The FDA's AI-enabled device list has passed roughly 1,500 authorizations, yet no device using g...

Medically Reviewed by: Dr Frank Yap, MD | Written by:     OneDayMD Editorial Team | Last Updated:   August  2026 Contents: Introduction Lymphoma Case Series (30 case reports) Leukemia Case Series (14 case reports) Discussion Conclusion Important Disclaimers:  This content is for educational purposes only and does not constitute medical advice. Ivermectin is used off-label for cancer treatment. Always consult with a knowledgeable physician whom you trust to manage your health. Individual results may vary. Do not self-medicate with ivermectin without proper bloodwork and medical monitoring, as misuse can lead to serious side effects and drug interactions. Ivermectin and mebendazole are used off-label as complementary therapies and are not intended to replace conventional, evidence-based cancer treatments such as chemotherapy, radiotherapy, immunotherapy, targeted therapy, or hormone therapy. Any off-label use should be discussed with and supervised by a quali...